Tofflon

Tofflon Science and Technology Group Co., Ltd. engages in the research, development, production, sales, and services of pharmaceutical equipment in China and internationally. The company offers technological research, including cell technology, complex preparation, injection, and OSD laboratory; instruments comprising cell therapy and nucleic acid drugs instruments, laboratory facilities, and table reactor; single use technology that include bioreactors, liquid distribution systems, sterile bags, process chromatography, membrane filtration systems, and others; and cryopreservation system for seeds and biological samples, as well as freeze-thaw system of biological stock solutions. It also provides culture medium, such as cell and gene therapy, biomacromolecule drugs, tobitec feeding medium, and other series; bioreactors, fermentation systems, cell factory, perfusion, and complementary systems; preparation systems, including bio-process vessel and piping, common solutions preparation, and complex injectable formulation systems; and separation and purification systems comprising disc centrifuge, membrane filtration, chromatography system and columns, alkali lysis, slurry tank, and filters.